In vitro enzymatic response of Turkish native chicken "Gerze" to heavy metal exposure

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 1, 2013, Pages 52-57

  Mercan, Levent ^a   Okumuş, Ahmet ^a   Şentürk, Murat ^b   Ekinci, Deniz ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b AGRI IBRAHIM CECEN UNIVERSITY   (Turkey)

Author keywords

Chicken, metal ions; Glucose 6 phosphate dehydrogenase; Purification

Indexed keywords

AMMONIUM SULFATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEAVY METAL;

ARTICLE; CHICKEN; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME KINETICS; ENZYME PURIFICATION; ERYTHROCYTE; HEMOLYSATE; IN VITRO STUDY; IONIC STRENGTH; NONHUMAN; PARAMETERS; PH MEASUREMENT; PRECIPITATION; PRIORITY JOURNAL; TISSUE HOMOGENATE;

ANIMALS; CHICKENS; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; KINETICS; METALS, HEAVY; NADP; TURKEY;

EID: 84874140266     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.627509     Document Type: Article

References (31)

1. Negwer M. Organic-chemical drugs and their synonyms. Berlin: Akademie Verlag, 1994:215-216,375,630-631,2972-2974
2. Sławiński J, Bednarski P, Reszka P. Syntheses and in vitro antitumor activity of 3-amino-N-(4-chlorobenzenesulfonyl)guanidine derivatives containing N'-arylidene moiety. Polish J Chem 2004;78:369-379 (Pubitemid 38407459)
3. Sławiński J. Synthesis of a new series of 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives with potential antitumor activity. Eur J Med Chem 2004;39:179-188 (Pubitemid 38249530)
4. Sławiński J, Gdaniec M. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives. Eur J Med Chem 2005;40:377-389 (Pubitemid 40460300)
5. Sławiński J, Brzozowski Z. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives. Eur J Med Chem 2006;41:1180-1189 (Pubitemid 44550221)
6. Brzozowski Z, Sa̧czewski F, Sławiński J, Bednarski PJ, Grünert R, Gdaniec M. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3- yl)arylsulfonamides. Bioorg Med Chem 2007;15:2560-2572 (Pubitemid 46367713)
7. Sławiński J, Brożewicz K, Fruziński A, Główka ML. Synthesis and antitumor activity of novel N'-(2-benzylthiobenzenesulfonyl)-1H-pyrazole-1-amidine derivatives. Heterocycles 2011;83:1093-1109
8. Kuo ChL, Assefa H, Brzozowski Z, Sławiński J, Sa̧czewski F, Buolamwini IK, Neamati NJ. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors. J Med Chem 2004;47:385-399 (Pubitemid 38057882)
9. Brzozowski Z, Sławiński J, Sa̧czewski F, Sanchez T, Neamati N. Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives. Eur J Med Chem 2008;43:1188-1198 (Pubitemid 351736010)
10. Brzozowski Z, Sa̧czewski F, Sławiński J, Sanchez T, Neamati N. Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro- 1,1-dioxo-1,4,2-benzodithiazines. Eur J Med Chem 2009;44:190-196
11. Saczewski F, Innocenti A, Brzozowski Z, Slawinski J, Pomarnacka E, Kornicka A et al. Carbonic anhydrase inhibitors. Selective inhibition of human tumor-associated isozymes IX and XII and cytosolic isozymes I and II with some substituted-2-mercapto-benzenesulfonamides. J Enzyme Inhib Med Chem 2006;21:563-568 (Pubitemid 44768466)
12. Sa̧czewski F, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Innocenti A et al. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors. Bioorg Med Chem Lett 2006;16:4846-4851 (Pubitemid 44177775)
13. Foroumadi A, Emami S, Hassanzadeh A, Rajaee M, Sokhanvar K, Moshafi MH et al. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2- yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. Bioorg Med Chem Lett 2005;15:4488-4492 (Pubitemid 41253880)
14. Kolavi G, Hegde V, Khazi I, Gadad P. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Bioorg Med Chem 2006;14:3069-3080
15. Hafez HN, Hegab MI, Ahmed-Farag IS, el-Gazzar AB. A facile regioselective synthesis of novel spiro-thioxanthene and spiro-xanthene-9′,2-[1,3,4] thiadiazole derivatives as potential analgesic and anti-inflammatory agents. Bioorg Med Chem Lett 2008;18:4538-4543
16. Kritsanida M, Mouroutsou A, Marakos P, Pouli N, Papakonstantinou- Garoufalias S, Pannecouque C et al. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4] thiadiazoles. Farmaco 2002;57:253-257 (Pubitemid 38365953)
17. Fujiwara M, Ijichi K, Konno K, Yokota T, Hanasaki Y, Watanabe H, Katsuura K, Shirakawa S, Takayama H, Sakai S, Shigeta S, Baba M. Thiadiazole derivatives as highly potent inhibitor of human immunodeficiency virus type 1 (HIV-1). Antiviral Res 1995;26:A254
18. Li Z, Wang X, Da Y. Synthesis of 2-(5-(2-chlorophenyl)-2-furoylamido)-5- aryloxymethyl-1,3,4-thiadiazoles under microwave irradiation. Synth Commun 2001;31:1829-1836
19. Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A. Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg Med Chem 2001;9:703-714 (Pubitemid 32208589)
20. Rzeski W, Matysiak J, Kandefer-Szerszen M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg Med Chem 2007;15:3201-3207 (Pubitemid 46484337)
21. Klayman DL, Bartosevich JF, Griffin TS, Mason CJ, Scovill JP. 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem 1979;22:855-862
22. Kubota S, Uda M, Mori Y, Kametani F, Terada H. Syntheses and uncoupling activities of alkyl dithiocarbazates and alkyl pyridinecarbonyldithiocarbazates. J Med Chem 1978;21:591-594 (Pubitemid 8349536)
23. Clinical Laboratory Standards Institute/ NCCLS: Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standards. 7th ed. CLSI document M11-A7. PA: Wayne, 2007
24. Forbes BA, Sahn DF, Weissfeld AS. Bailey and Scott's Diagnostics Microbiology. 12th ed. St. Louis: Mosby Elsevier, 2007
25. Murray PR, editor. Manual of Clinical Microbiology. 9th ed. Washington, DC: American Society for Microbiology Press, 2007
26. Clinical Laboratory Standards Institute/ NCCLS: Methods of dilution antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standards. 7th ed. CLSI document M7-A7. PA: Wayne, 2006
27. Brzozowski Z, Sławiński J. [1,1-dioxo-1,4,2-benzodithiazine derivatives. I. Synthesis of various 7-carboxy-3-mercapto-1,1-dioxo-1,4,2- benzodithiazine]. Acta Pol Pharm 1984;41:5-13
28. Brzozowski Z, Sławiński J. Pochodne 1,1-diokso-1,4,2- benzoditiazyny. 2. Syntezy niektórych pochodnych 3-merkapto-1,1-diokso-1, 4,2-benzoditiazyny. Acta Polon Pharm 1984;41:133-139
29. Sławiński J. Syntheses and some reactions of 3-amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiazine. Pol J Chem 2001;75:1309-1316
30. Evers R, Fischer E, Pulkenat M. Struktur und Reaktionsverhalten aktivierter C-N-Doppelbindungen. Synthese substituierter 1,3,4-Thiadiazole. Z Chem 1980;20:413-414
31. García-Galán MaJ, Díaz-Cruz MS, Barceló D. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. TrAC Trends in Anal Chem 2008;27:1008-1022